Back

TISON: a next-generation multi-scale modeling theatre for in silico systems oncology

Gondal, M. N.; Sultan, M. U.; Arif, A.; Rehman, A.; Awan, H. A.; Arshad, Z.; Ahmed, W.; Chaudhary, M. F.; Khan, S.; Tanveer, Z. B.; Butt, R. N.; Hussain, R.; Khawar, H.; Amina, B.; Akbar, R.; Abbas, F.; Jami, M. N.; Nasir, Z.; Shah, O. S.; Hameed, H.; Butt, M. F.; Mustafa, G.; Ahmad, M. M.; Ahmed, S.; Qazi, R.; Ahmed, F.; Ishaq, O.; Nabi, S. W.; Vanderbauwhede, W.; Wajid, B.; Shehwana, H.; Uddin, E.; Safdar, M.; Javed, I.; Tariq, M.; Faisal, A.; Chaudhary, S. U.

2021-05-05 systems biology
10.1101/2021.05.04.442539 bioRxiv
Show abstract

Multi-scale models integrating biomolecular data from genetic, transcriptional, and translational levels, coupled with extracellular microenvironments can assist in decoding the complex mechanisms underlying system-level diseases such as cancer. To investigate the emergent properties and clinical translation of such cancer models, we present Theatre for in silico Systems Oncology (TISON, https://tison.lums.edu.pk), a next-generation web-based multi-scale modeling and simulation platform for in silico systems oncology. TISON provides a "zero-code" environment for multi-scale model development by seamlessly coupling scale-specific information from biomolecular networks, microenvironments, cell decision circuits, in silico cell lines, and organoid geometries. To compute the temporal evolution of multi-scale models, a simulation engine and data analysis features are also provided. Furthermore, TISON integrates patient-specific gene expression data to evaluate patient-centric models towards personalized therapeutics. Several literature-based case studies have been developed to exemplify and validate TISONs modeling and analysis capabilities. TISON provides a cutting-edge multi-scale modeling pipeline for scale-specific as well as integrative systems oncology that can assist in drug target discovery, repositioning, and development of personalized therapeutics.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
npj Systems Biology and Applications
99 papers in training set
Top 0.1%
23.3%
2
PLOS Computational Biology
1633 papers in training set
Top 4%
8.7%
3
Bioinformatics
1061 papers in training set
Top 4%
5.0%
4
iScience
1063 papers in training set
Top 2%
5.0%
5
npj Digital Medicine
97 papers in training set
Top 0.9%
4.5%
6
Computers in Biology and Medicine
120 papers in training set
Top 0.6%
4.1%
50% of probability mass above
7
Briefings in Bioinformatics
326 papers in training set
Top 1%
4.1%
8
PLOS ONE
4510 papers in training set
Top 37%
3.7%
9
BMC Bioinformatics
383 papers in training set
Top 3%
3.7%
10
Computational and Structural Biotechnology Journal
216 papers in training set
Top 2%
3.2%
11
Quantitative Biology
11 papers in training set
Top 0.1%
2.2%
12
Patterns
70 papers in training set
Top 0.5%
2.2%
13
npj Precision Oncology
48 papers in training set
Top 0.4%
2.0%
14
Bulletin of Mathematical Biology
84 papers in training set
Top 1%
1.7%
15
Gigabyte
60 papers in training set
Top 0.7%
1.5%
16
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.5%
17
Bioinformatics Advances
184 papers in training set
Top 3%
1.4%
18
Scientific Reports
3102 papers in training set
Top 65%
1.3%
19
Nature Machine Intelligence
61 papers in training set
Top 3%
0.7%
20
Frontiers in Genetics
197 papers in training set
Top 10%
0.7%
21
Integrative Biology
13 papers in training set
Top 0.2%
0.7%
22
Nature Medicine
117 papers in training set
Top 6%
0.7%
23
Nature Communications
4913 papers in training set
Top 66%
0.5%
24
BMC Medical Informatics and Decision Making
39 papers in training set
Top 3%
0.5%
25
Cancer Immunology, Immunotherapy
11 papers in training set
Top 0.5%
0.5%
26
Cell Systems
167 papers in training set
Top 14%
0.5%
27
Cancers
200 papers in training set
Top 6%
0.5%
28
IEEE Access
31 papers in training set
Top 1%
0.5%
29
Database
51 papers in training set
Top 1%
0.5%
30
APL Bioengineering
18 papers in training set
Top 0.5%
0.5%